Persistent Risk of Developing Autoimmune Diseases Associated With COVID-19: An Observational Study Using an...

Area of Science:

• Immunology
• Infectious Diseases
• Public Health

Background:

• Emerging evidence suggests viral infections can trigger autoimmune responses.
• The long-term impact of coronavirus disease 2019 (COVID-19) on autoimmune disease development requires further investigation.

Purpose of the Study:

• To investigate the association between COVID-19 and the risk of developing autoimmune diseases in Japan.
• To examine both short-term and long-term risks, as well as variant-specific risks.

Main Methods:

• Observational study utilizing a Japanese electronic medical record database.
• Comparison of autoimmune disease incidence between COVID-19 patients and a non-COVID-19 cohort.
• Risk assessment using standardized mortality ratio weighting and Cox proportional hazards models, with subgroup analyses for variants and timeframes.

Main Results:

• A total of 90,855 COVID-19 patients and 459,827 controls were analyzed.
• COVID-19 was associated with a 2.32-fold increased relative risk of any autoimmune disease.
• Significant risks were observed for specific diseases like rheumatoid arthritis, systemic sclerosis, and IgG4-related disease, with substantial long-term risks for the latter two.

Conclusions:

• COVID-19 is linked to a persistent, increased risk of autoimmune diseases in the Japanese population.
• The findings highlight a significant long-term association between viral infections and autoimmunity.
• Variant-specific risks and long-term implications warrant continued monitoring.